JANX vs REGN: Which Stock is Better?

Side-by-side comparison of Janux Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

JANX

Janux Therapeutics Inc

$15.24

REGN

Regeneron Pharmaceuticals Inc

$746.46

Key Metrics Comparison

MetricJANXREGNWinner
Market Cap$906.39M$79.17BREGN
P/E RatioN/A18.05REGN
EPS (TTM)$N/A$41.49REGN
Revenue Growth21.8%0.0%JANX
Gross Margin-1159.0%44.6%REGN

Analyze JANX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is JANX or REGN a better investment?

Comparing JANX and REGN: Janux Therapeutics Inc has a market cap of $906.39M while Regeneron Pharmaceuticals Inc has $79.17B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between JANX and REGN?

JANX (Janux Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: JANX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: JANX or REGN?

JANX has higher revenue growth at 21.8% vs 0.0% for REGN.

Which company is more profitable: JANX or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -1159.0% for JANX.

Which is the larger company: JANX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.17B compared to $906.39M for JANX.

Should I buy JANX or REGN in 2026?

Both JANX and REGN have investment merit. JANX trades at $15.24 while REGN trades at $746.46. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between JANX and REGN stock?

Key differences: Market Cap ($906.39M vs $79.17B), P/E Ratio (N/A vs 18.0x), Revenue Growth (21.8% vs 0.0%), Gross Margin (-1159.0% vs 44.6%).

Popular Stock Comparisons